Combined Intrathecal Dexmedetomidine and Adductor Canal Block for Analgesia after Knee Surgeries

Phase 2

• Conditions: Orthopaedics; Anaesthesia

• Registration Number: PACTR202304775359949
• Lead Sponsor: Faculty of Medicine Kafr Elsheikh University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-03-25
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

•Patient’s approval.
•Age: 30 – 65years.
•Sex: Both males and females.
•Physical Status: American Society of Anesthesiologists
(ASA) I & II.

Exclusion Criteria

•Patient refusal
•Age: >65 and <30 years.
•Allergy to Dexmedetomidine, local anesthetics, systemic opioids and any of the drugs included in the multimodal perioperative pain protocol.
•Revision surgery.
• Patients with impaired kidney functions and coagulopathy.
• Chronic pain syndromes and patients with chronic opioid use defined as use of regular daily doses of systemic narcotics for the past 6 months prior to the surgery.
• BMI of 40 or more.
• Physical Status: American Society of Anesthesiologists (ASA) III & IV.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Visual Analogue Scale (VAS) Scale

Secondary Outcome Measures

Name	Time	Method
1.Time to first rescue analgesia.<br>2.Total Morphine consumption in the first 24 hours.<br>3.Anesthetic complications<br>